Search research articles
Contact Us
Filters
Showing results (211-220 of 341) with videos related to
Page
of 35
Sort By:
Skin Pharmacology and Physiology
|
February 23, 2012
Bioavailability, antipsoriatic efficacy and tolerability of a new light cream with mometasone furoate 0.1%
H C Korting, C Schöllmann, C Willers, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 1, 1995
In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new
M J Kerscher, H Hart, H C Korting, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 1, 1995
Molecular evidence for the existence of disseminated zoster as a distinct entity in an immunosuppressed renal transplant patient
E M Schlüpen, H C Korting, F Nachbar, et al.
International Journal of Antimicrobial Agents
|
February 13, 2001
Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts
J Bastert, M Schaller, H C Korting, et al.
Skin Pharmacology and Physiology
|
September 29, 2004
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects
G Weindl, M Schaller, M Schäfer-Korting, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
July 1, 1984
Ketoconazole concentrations in human skin blister fluid and plasma
M Schäfer-Korting, H C Korting, M Dorn, et al.
The Clinical Investigator
|
August 1, 1993
Influence of topical erythromycin preparations for acne vulgaris on skin surface pH
H C Korting, M Kerscher, M Schäfer-Korting, et al.
Der Internist
|
May 1, 1988
[Fever with vesicular exanthema and pharyngitis in a 20-year-old patient (Mycoplasma pneumoniae associated Stevens-Johnson syndrome)]
J Pauletzki, G A Mannes, T Sauerbruch, et al.
Acta Dermato-Venereologica
|
January 1, 1987
Can the clinical efficacy of different antibiotic dosage regimens in gonorrhoea be predicted from the gonocidal effect of the corresponding plasma level profiles simulated in vitro?
H C Korting, M Ollert, A Lukacs, et al.
Skin Pharmacology and Physiology
|
December 21, 2004
Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases
A Roeder, M Schaller, M Schäfer-Korting, et al.
Page
of 35
Search research articles
Search
Showing results (211-220 of 341) with videos related to
Sort By:
Page
of 35
Skin Pharmacology and Physiology
|
February 23, 2012
Bioavailability, antipsoriatic efficacy and tolerability of a new light cream with mometasone furoate 0.1%
H C Korting, C Schöllmann, C Willers, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 1, 1995
In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new
M J Kerscher, H Hart, H C Korting, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 1, 1995
Molecular evidence for the existence of disseminated zoster as a distinct entity in an immunosuppressed renal transplant patient
E M Schlüpen, H C Korting, F Nachbar, et al.
International Journal of Antimicrobial Agents
|
February 13, 2001
Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts
J Bastert, M Schaller, H C Korting, et al.
Skin Pharmacology and Physiology
|
September 29, 2004
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects
G Weindl, M Schaller, M Schäfer-Korting, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
July 1, 1984
Ketoconazole concentrations in human skin blister fluid and plasma
M Schäfer-Korting, H C Korting, M Dorn, et al.
The Clinical Investigator
|
August 1, 1993
Influence of topical erythromycin preparations for acne vulgaris on skin surface pH
H C Korting, M Kerscher, M Schäfer-Korting, et al.
Der Internist
|
May 1, 1988
[Fever with vesicular exanthema and pharyngitis in a 20-year-old patient (Mycoplasma pneumoniae associated Stevens-Johnson syndrome)]
J Pauletzki, G A Mannes, T Sauerbruch, et al.
Acta Dermato-Venereologica
|
January 1, 1987
Can the clinical efficacy of different antibiotic dosage regimens in gonorrhoea be predicted from the gonocidal effect of the corresponding plasma level profiles simulated in vitro?
H C Korting, M Ollert, A Lukacs, et al.
Skin Pharmacology and Physiology
|
December 21, 2004
Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases
A Roeder, M Schaller, M Schäfer-Korting, et al.
Page
of 35